Production (Stage)
Ovid Therapeutics Inc.
OVID
$0.3186
$0.00531.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.48% | 39.61% | -24.48% | 168.66% | 12.44% |
| Total Depreciation and Amortization | 3.68% | 14.29% | 15.75% | 8.03% | -6.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 132.97% | 83.81% | -43.90% | -1,801.88% | -347.48% |
| Change in Net Operating Assets | 25.11% | -123.34% | -6,117.24% | 507.79% | -544.44% |
| Cash from Operations | 38.39% | 15.98% | -49.29% | -21.78% | -37.76% |
| Capital Expenditure | -- | -69.23% | 166.67% | -385.71% | -35.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -74.75% | 143.94% | 106.61% | -35.95% | -33.18% |
| Cash from Investing | -74.73% | 143.89% | 106.70% | -36.10% | -33.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.30% | -100.00% | -83.04% | 68.72% | 240.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.30% | -100.00% | -83.04% | 68.72% | 240.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -200.00% | 200.00% |
| Net Change in Cash | -238.43% | 137.13% | -3.45% | -112.58% | -79.48% |